InMed Pharmaceuticals (INM) Accounts Payables (2020 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Accounts Payables of $1.0 million for Q1 2026, down 28.24% year-over-year from $1.4 million in Q1 2025, and down 5.63% quarter-over-quarter from $1.1 million in Q4 2025.
InMed Pharmaceuticals (INM) Accounts Payables (2020 - 2026) Analysis & Trends
InMed Pharmaceuticals' Accounts Payables history runs 7 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 28.24% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (down 28.24% YoY), while the FY2025 annual figure was $1.2 million, down 25.58% from the prior year.
- Accounts Payables for Q1 2026 stood at $1.0 million, down from $1.1 million in the prior quarter.
- The five-year high for Accounts Payables was $2.4 million in Q2 2022, with the low at $2000.0 in Q3 2024.
- The 5-year median for Accounts Payables is $1.3 million (2022), against an average of $1.3 million.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables plunged 99.47% in 2024, then surged 56410.95% in 2025.
- InMed Pharmaceuticals' Accounts Payables stood at $2.0 million in 2022, then tumbled by 34.65% to $1.3 million in 2023, then grew by 6.49% to $1.4 million in 2024, then dropped by 21.83% to $1.1 million in 2025, then dropped by 5.63% to $1.0 million in 2026.
- Business Quant data shows INM's Accounts Payables at $1.0 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | InMed Pharmaceuticals | 6.48 Mn | 1.24 Mn | - | 1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.01 Mn |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 1.65 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 379,866.00 |
| Jun 30, 2023 | 544,179.00 |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 1.97 Mn |
| Sep 30, 2022 | 2.36 Mn |
| Jun 30, 2022 | 2.42 Mn |
| Mar 31, 2022 | 1.26 Mn |
| Dec 31, 2021 | 3.36 Mn |
| Sep 30, 2021 | 1.84 Mn |
| Jun 30, 2021 | 2.13 Mn |